Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.

By K. Marr, R. Carter, M. Boeckh, P. Martin, L. Corey. Blood, 2002

960 citations recorded by the source corpus.

Subfields: Epidemiology, Infectious Diseases

View Paper: https://www.semanticscholar.org/paper/b043cae41f5a575beb7ab784fb24590f49b2c915

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

In Infectious Diseases

Citations in the corpus

Immunity to fungal infections (2011, background): “, as well as with the onset of graft-versus-host disease in bone-marrow-transplant recipient”
Aspergillus Infections in Transplant Recipients (2005, background): “Transplantation practices, immunosuppressive regimens, and the characteristics of patients undergoing transplantation have continued to evolve (87, 136, 186, 296).”
Hospital Epidemiology and Infection Control in Acute-Care Settings (2011, background): “In those having undergone hematopoietic stem cell transplants, the incidence of invasive Aspergillus infections is bimodal, with increased rates of infection seen at 2 weeks and then again at 3 months posttransplant (201, 335).”
Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. (2008, background): “Invasive aspergillosis currently constitutes the most common cause of infectious pneumonic mortality in patients undergoing HSCT and is an important cause of opportunistic respiratory and disseminated infection in other immunocompromised patients [5–11].”
Epidemiology of Invasive Mycoses in North America (2010, background): “C. glabrata has emerged as an important and potentially antifungal-resistant opportunistic fungal pathogen (Abi-Said et al. 1997; Alexander et al. 2005; Antoniadou et al. 2003; Diekema et al. 2002; Eggimann et al. 2003; Hachem et al. 2008; Hajjeh et al. 2004; Horn et al. 2009; Kao et al. 1999; Kleva”
Pathogenesis of Aspergillus fumigatus in Invasive Aspergillosis (2009, background): “as leukemia; solid-organ and hematopoietic stem cell transplant patients; patients on prolonged corticosteroid therapy, which is commonly utilized for the prevention and/or treatment of graft-versus-host disease in transplant patients; individuals with genetic immunodeficiencies such as chronic gran”
Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. (2009, background): “infections have become more common [3, 4].”